Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella typhimurium DT104 in England and Wales

E J Threlfall; L. R. Ward; B Rowe

doi:10.2807/esm.02.11.00187-en

Surveillance report Open Access

Like 0

This item has no PDF Download

Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella typhimurium DT104 in England and Wales
E J Threlfall¹ , L. R. Ward¹ , B Rowe¹
View Affiliations Hide Affiliations

Affiliations: ¹ WHO Collaborating Centre for Phage Typing and Drug Resistance in Enterobacteria, Public Health Laboratory Service Laboratory of Enteric Pathogens, Central Public Health Laboratory, London, England.

Correspondence:
View Citation Hide Citation

Citation style for this article: Threlfall E J, Ward L. R., Rowe B. Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella typhimurium DT104 in England and Wales. Euro Surveill. 1997;2(11):pii=187. https://doi.org/10.2807/esm.02.11.00187-en

Previous Article
Table of Contents
Next Article

Abstract

Salmonella typhimurium definitive phage type (DT) 104 (= DT104) with chromosomally-encoded resistance to ampicillin, chloramphenicol, streptomycin, sulphonamides, and tetracyclines (= R-type ACSSuT) has become increasingly common in humans in England and